Citation
Haybar, Habib, et al. "The Effects of Melissa Officinalis Supplementation On Depression, Anxiety, Stress, and Sleep Disorder in Patients With Chronic Stable Angina." Clinical Nutrition ESPEN, vol. 26, 2018, pp. 47-52.
Haybar H, Javid AZ, Haghighizadeh MH, et al. The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clin Nutr ESPEN. 2018;26:47-52.
Haybar, H., Javid, A. Z., Haghighizadeh, M. H., Valizadeh, E., Mohaghegh, S. M., & Mohammadzadeh, A. (2018). The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina. Clinical Nutrition ESPEN, 26, 47-52. https://doi.org/10.1016/j.clnesp.2018.04.015
Haybar H, et al. The Effects of Melissa Officinalis Supplementation On Depression, Anxiety, Stress, and Sleep Disorder in Patients With Chronic Stable Angina. Clin Nutr ESPEN. 2018;26:47-52. PubMed PMID: 29908682.
TY - JOUR
T1 - The effects of Melissa officinalis supplementation on depression, anxiety, stress, and sleep disorder in patients with chronic stable angina.
AU - Haybar,Habib,
AU - Javid,Ahmad Zare,
AU - Haghighizadeh,Mohammad Hosein,
AU - Valizadeh,Einollah,
AU - Mohaghegh,Seyede Marjan,
AU - Mohammadzadeh,Assieh,
Y1 - 2018/05/19/
PY - 2017/12/14/received
PY - 2018/04/05/revised
PY - 2018/04/25/accepted
PY - 2018/6/18/entrez
PY - 2018/6/18/pubmed
PY - 2019/9/11/medline
KW - Anxiety
KW - Chronic stable angina
KW - Depression
KW - Melissa officinalis
KW - Stress
SP - 47
EP - 52
JF - Clinical nutrition ESPEN
JO - Clin Nutr ESPEN
VL - 26
N2 - BACKGROUND: Despite advances in the treatment of cardiovascular diseases in recent decades, patients experience high levels of depression, anxiety, stress, and insomnia. Since the calming effect of Melissa officinalis (MO) has been known, this study aimed to determine the effects of MO supplementation on depression, anxiety, stress, and sleep disturbances in patients with chronic stable angina (CSA). METHODS: In this double-blind placebo-controlled clinical trial, 80 patients with CSA were divided randomly into two groups (taking 3 g MO supplement or placebo daily for 8 weeks). The shortened 21-item version of the depression, anxiety and stress scale (DASS-21) test and Pittsburgh sleep quality index were done before and after the intervention. RESULTS: At the end of the study, the intervention group receiving MO capsules had a significant reduction in scores of depression, anxiety, stress, and total sleep disturbance, compared with the placebo group (P < 0.05). CONCLUSIONS: The results showed that 8-week supplementation with 3 g MO can decrease depression, anxiety, stress, and sleep disorder in patients with CSA.
SN - 2405-4577
UR - https://neuro.unboundmedicine.com/medline/citation/29908682/The_effects_of_Melissa_officinalis_supplementation_on_depression_anxiety_stress_and_sleep_disorder_in_patients_with_chronic_stable_angina_
DB - PRIME
DP - Unbound Medicine
ER -